T-Therapeutics
United KingdomEntry
2023
Hold
3yr
Status
Active
Who owns T-Therapeutics?
T-Therapeutics is a British Biotech company, currently owned by BGF since 2025 and 2 other investors.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Most recent investor
Cambridge Innovation CapitalCIC Fund II · 2022 · VC
3 ownership periods · full history below
Key facts
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2023 · present
Sofinnova PartnersActive
2023 · present(3yr) · Sofinnova Capital X · 2021 · Life Sciences VC
BGFActive
2025 · present(1yr) · BGF · 2011 · Evergreen
More from CIC Fund II
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns T-Therapeutics?
T-Therapeutics is currently owned by BGF, Sofinnova Partners and 1 other, through CIC Fund II, since 2025.
When did BGF and 2 others acquire T-Therapeutics?
BGF and 2 others acquired T-Therapeutics in 2025.
Who has owned T-Therapeutics over time?
T-Therapeutics has been through 3 private-equity ownership periods: Sofinnova Partners · via Sofinnova Capital X · since 2023; Cambridge Innovation Capital · via CIC Fund II · since 2023; BGF · via BGF · since 2025.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue